| Meta-analysis of tumor-and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition K Litchfield, JL Reading, C Puttick, K Thakkar, C Abbosh, R Bentham, ... Cell 184 (3), 596-614. e14, 2021 | 676 | 2021 |
| Pervasive chromosomal instability and karyotype order in tumour evolution TBK Watkins, EL Lim, M Petkovic, S Elizalde, NJ Birkbak, GA Wilson, ... Nature 587 (7832), 126-132, 2020 | 319 | 2020 |
| Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers CF Houlihan, N Vora, T Byrne, D Lewer, G Kelly, J Heaney, S Gandhi, ... The Lancet 396 (10246), e6-e7, 2020 | 249 | 2020 |
| Metastasis and immune evasion from extracellular cGAMP hydrolysis J Li, MA Duran, N Dhanota, WK Chatila, SE Bettigole, J Kwon, RK Sriram, ... Cancer discovery 11 (5), 1212-1227, 2021 | 213 | 2021 |
| Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse F Chemi, DG Rothwell, N McGranahan, S Gulati, C Abbosh, SP Pearce, ... Nature medicine 25 (10), 1534-1539, 2019 | 189 | 2019 |
| An innate-like Vδ1+ γδ T cell compartment in the human breast is associated with remission in triple-negative breast cancer Y Wu, F Kyle-Cezar, RT Woolf, C Naceur-Lombardelli, J Owen, D Biswas, ... Science translational medicine 11 (513), eaax9364, 2019 | 155 | 2019 |
| Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA C Abbosh, AM Frankell, T Harrison, J Kisistok, A Garnett, L Johnson, ... Nature 616 (7957), 553-562, 2023 | 149 | 2023 |
| The evolution of lung cancer and impact of subclonal selection in TRACERx AM Frankell, M Dietzen, M Al Bakir, EL Lim, T Karasaki, S Ward, ... Nature 616 (7957), 525-533, 2023 | 147 | 2023 |
| A clonal expression biomarker associates with lung cancer mortality D Biswas, NJ Birkbak, R Rosenthal, CT Hiley, EL Lim, K Papp, S Boeing, ... Nature medicine 25 (10), 1540-1548, 2019 | 97 | 2019 |
| The T cell differentiation landscape is shaped by tumour mutations in lung cancer E Ghorani, JL Reading, JY Henry, MR Massy, R Rosenthal, V Turati, ... Nature cancer 1 (5), 546-561, 2020 | 94 | 2020 |
| A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer Y Wu, D Biswas, I Usaite, M Angelova, S Boeing, T Karasaki, S Veeriah, ... Nature cancer 3 (6), 696-709, 2022 | 74 | 2022 |
| Scalable and robust SARS-CoV-2 testing in an academic center J Aitken, K Ambrose, S Barrell, R Beale, G Bineva-Todd, D Biswas, ... Nature biotechnology 38 (8), 927-931, 2020 | 49* | 2020 |
| Evolutionary characterization of lung adenocarcinoma morphology in TRACERx T Karasaki, DA Moore, S Veeriah, C Naceur-Lombardelli, A Toncheva, ... Nature medicine 29 (4), 833-845, 2023 | 47 | 2023 |
| Impact of cancer evolution on immune surveillance and checkpoint inhibitor response Y Wu, D Biswas, C Swanton Seminars in cancer biology 84, 89-102, 2022 | 30 | 2022 |
| RAS oncogenic activity predicts response to chemotherapy and outcome in lung adenocarcinoma P East, GP Kelly, D Biswas, M Marani, DC Hancock, T Creasy, ... Nature communications 13 (1), 5632, 2022 | 26 | 2022 |
| Clinical outcomes of COVID-19 in long-term care facilities for people with epilepsy S Balestrini, MJ Koepp, S Gandhi, HM Rickman, GY Shin, CF Houlihan, ... Epilepsy & Behavior 115, 107602, 2021 | 16 | 2021 |
| PD-1 defines a distinct, functional, tissue-adapted state in Vδ1+ T cells with implications for cancer immunotherapy D Davies, S Kamdar, R Woolf, I Zlatareva, ML Iannitto, C Morton, Y Haque, ... Nature Cancer 5 (3), 420-432, 2024 | 15 | 2024 |
| Artificial intelligence methods for improved detection of undiagnosed heart failure with preserved ejection fraction J Wu, D Biswas, M Ryan, BS Bernstein, M Rizvi, N Fairhurst, G Kaye, ... European Journal of Heart Failure 26 (2), 302-310, 2024 | 15 | 2024 |
| The future of liquid biopsy D Biswas, J Ganeshalingam, JCM Wan The Lancet Oncology 21 (12), e550, 2020 | 13 | 2020 |
| Tracing evolution reveals new biomarkers P Sidaway Nature Reviews Clinical Oncology 17 (1), 5-5, 2020 | 3 | 2020 |
Charles SwantonFrancis Crick InstituteBestätigte E-Mail-Adresse bei crick.ac.uk
